Literature DB >> 1955861

Purification and some properties of carboxynorspermidine synthase participating in a novel biosynthetic pathway for norspermidine in Vibrio alginolyticus.

H Nakao1, S Shinoda, S Yamamoto.   

Abstract

Carboxynorspermidine synthase, mediates the nicotinamide-nucleotide-linked reduction of the Schiff base H2N(CH2)3N = CHCH2CH(NH2)COOH. This is formed from L-aspartic beta-semialdehyde (ASA) and 1,3-diaminopropane (DAP) and is reduced to carboxynorspermidine [H2N(CH2)3NH(CH2)2CH(NH2)COOH], an intermediate in the novel pathway for norspermidine (NSPD) biosynthesis. The enzyme was purified to apparent homogeneity from Vibrio alginolyticus and characterized. The overall purification was about 1800-fold over the crude extract, with a yield of 33%. The enzyme displayed an apparent Mr of 93500 +/- 1000 by gel filtration and 45100 +/- 500 by SDS-PAGE, indicating that the native form is probably composed of two subunits of similar size. The specific activity of the purified enzyme was 31.0 mumol carboxynorspermidine produced min-1 (mg protein)-1. The enzyme was activated by dithiothreitol, and inhibited by SH-reactive compounds. The pH and temperature optima were 7.25-7.5 and 37 degrees C, respectively. The Km value for the Schiff base was 4.68 mM, measured by varying the ASA concentration while keeping the DAP concentration constant. Putrescine was slightly active as a substrate, forming carboxyspermidine (at about 7% of the rate of DAP), but ethylenediamine, cadaverine and D-ASA were inert. The Km value for NADPH was 1.51 mM. NADH was a much poorer cofactor than NADPH. When V. alginolyticus was grown in the presence of 5 mM-NSPD, the specific activity of this enzyme was reduced by approximately 70%. NSPD also repressed two other enzymes responsible for its biosynthesis, 2,4-diaminobutyrate decarboxylase and carboxynorspermidine decarboxylase.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1955861     DOI: 10.1099/00221287-137-7-1737

Source DB:  PubMed          Journal:  J Gen Microbiol        ISSN: 0022-1287


  7 in total

1.  Elevated levels of the norspermidine synthesis enzyme NspC enhance Vibrio cholerae biofilm formation without affecting intracellular norspermidine concentrations.

Authors:  Zachary M Parker; Samuel S Pendergraft; Jim Sobieraj; Marcus M McGinnis; Ece Karatan
Journal:  FEMS Microbiol Lett       Date:  2012-01-30       Impact factor: 2.742

2.  Evolution and multifarious horizontal transfer of an alternative biosynthetic pathway for the alternative polyamine sym-homospermidine.

Authors:  Frances L Shaw; Katherine A Elliott; Lisa N Kinch; Christine Fuell; Margaret A Phillips; Anthony J Michael
Journal:  J Biol Chem       Date:  2010-03-01       Impact factor: 5.157

3.  Highly efficient biosynthesis of spermidine from L-homoserine and putrescine using an engineered Escherichia coli with NADPH self-sufficient system.

Authors:  Xinxin Liang; Huaxiang Deng; Yajun Bai; Tai-Ping Fan; Xiaohui Zheng; Yujie Cai
Journal:  Appl Microbiol Biotechnol       Date:  2022-08-06       Impact factor: 5.560

Review 4.  Polyamines in Eukaryotes, Bacteria, and Archaea.

Authors:  Anthony J Michael
Journal:  J Biol Chem       Date:  2016-06-07       Impact factor: 5.157

5.  An alternative polyamine biosynthetic pathway is widespread in bacteria and essential for biofilm formation in Vibrio cholerae.

Authors:  Jeongmi Lee; Vanessa Sperandio; Doug E Frantz; Jamie Longgood; Andrew Camilli; Margaret A Phillips; Anthony J Michael
Journal:  J Biol Chem       Date:  2009-02-05       Impact factor: 5.157

6.  Alternative spermidine biosynthetic route is critical for growth of Campylobacter jejuni and is the dominant polyamine pathway in human gut microbiota.

Authors:  Colin C Hanfrey; Bruce M Pearson; Stuart Hazeldine; Jeongmi Lee; Duncan J Gaskin; Patrick M Woster; Margaret A Phillips; Anthony J Michael
Journal:  J Biol Chem       Date:  2011-10-24       Impact factor: 5.157

7.  Norspermidine is not a self-produced trigger for biofilm disassembly.

Authors:  Laura Hobley; Sok Ho Kim; Yukari Maezato; Susan Wyllie; Alan H Fairlamb; Nicola R Stanley-Wall; Anthony J Michael
Journal:  Cell       Date:  2014-02-13       Impact factor: 41.582

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.